Introduction: Inflammatory bowel disease has been associated with a number of cutaneous and systemic neutrophilic disorders, including pyoderma gangrenosum. In 1972, the term chronic multi-focal recurrent osteomyelitis was given to a sterile neutrophilic condition which has been associated with inflammatory bowel disease. Case Report: We report a case of a 23-year-old a sterile neutrophilic disorder which can present with bone pain and responds to immunosuppressive therapy.
CASE REPORT

DISCUSSION
The term CRMO was first described in 1972 as an unusual form of multi-focal bone lesions encompassing subacute and chronic symmetrical osteomyelitis [1, 2] . It is characterized by self-limiting but relapsing episodes of non-infectious osteomyelitis.
Although of unknown etiology, CRMO has recognized association with a number of dermatoses, particularly the neutrophilic dermatoses of PG, Crohn's and Sweet's syndrome [3, 4] . Its association with IBD was first reported in 1998 [5] , and the diagnosis may precede the development of bowel symptoms by around 5 years [6] . More recently, it has been suggested that CRMO may represent a pediatric form of SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis), and should be considered as an auto-inflammatory syndrome [7] .
Patients are usually children who present with recurrent episodes of bone pain, general malaise and raised inflammatory markers, which may be initially misdiagnosed as infective osteomyelitis or neoplasia [8] . The main sites of reported involvement are the tibia, pelvis, femur and clavicle [8] . Nonsteroidal anti-inflammatory drugs are often used as first-line treatment with good response.
Second-line options include bisphosphonates, systemic immunosuppressive drugs and rarely, such as in our case, TNF antagonists [6, 8, 9] . While oral steroids are effective in the majority of cases they are generally not used due to the side effects of long-term treatment. Follow-up studies have shown that the disease can remain active for around 10 years, highlighting its chronic and recurrent nature [10] .
The author wishes to highlight the increasingly recognized phenomenon of CRMO and in particular document the previously unreported correlation between episodes of severe back pain and flares of PG. It is inevitably important to consider CRMO in the differential diagnosis of back pain as treatment options involve immunosuppression rather than the high-dose prolonged antibiotic therapy required for infective osteomyelitis. In this patient, anti-TNF therapy that was originally instigated for control of bowel symptoms also ameliorated PG and his back pain due to CRMO.
CONCLUSION
In conclusion, we report a case of a young man with the background of PG and IBD who presented with severe back pain as part of a rare condition of CRMO. Accurate identification and diagnosis of this condition enables timely treatment with minimal sequelae.
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